See more : Polimex-Mostostal S.A. (PXM.WA) Income Statement Analysis – Financial Results
Complete financial analysis of The Hash Corporation (REZN.CN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of The Hash Corporation, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- XP Inc. (XP) Income Statement Analysis – Financial Results
- China Longyuan Power Group Corporation Limited (CLPXY) Income Statement Analysis – Financial Results
- The Hartford Financial Services Group, Inc. (0J3H.L) Income Statement Analysis – Financial Results
- Great Wall Motor Company Limited (GWLLY) Income Statement Analysis – Financial Results
- Polyplex Corporation Limited (POLYPLEX.NS) Income Statement Analysis – Financial Results
The Hash Corporation (REZN.CN)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.thehashcorporation.com
About The Hash Corporation
The Hash Corporation focuses on the production and sale of cannabis-based hashish and other cannabis products in Canada. The company was formerly known as Senternet Phi Gamma Inc. and changed its name to The Hash Corporation in July 2019. The Hash Corporation was incorporated in 1967 and is headquartered in Toronto, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 553.96K | 805.60K | 892.39K | 0.00 | 0.00 |
| Cost of Revenue | 236.22K | 423.57K | 618.45K | 18.68K | 0.00 |
| Gross Profit | 317.73K | 382.03K | 273.95K | -18.68K | 0.00 |
| Gross Profit Ratio | 57.36% | 47.42% | 30.70% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 583.60K | 1.60M | 4.80M | 2.00M | 2.04M |
| Selling & Marketing | 0.00 | 25.77K | 543.99K | 0.00 | 0.00 |
| SG&A | 583.60K | 1.60M | 4.80M | 2.00M | 2.04M |
| Other Expenses | 0.00 | 137.74K | 106.41K | 18.68K | 0.00 |
| Operating Expenses | 583.60K | 1.74M | 4.91M | 2.02M | 2.04M |
| Cost & Expenses | 819.82K | 2.16M | 5.53M | 2.02M | 2.04M |
| Interest Income | 0.00 | 52.56K | 4.45K | 0.00 | 0.00 |
| Interest Expense | 81.23K | 52.56K | 4.45K | 0.00 | 0.00 |
| Depreciation & Amortization | 72.89K | 137.74K | 106.41K | 18.68K | 171.86K |
| EBITDA | -265.86K | -1.22M | -4.53M | -2.00M | -2.04M |
| EBITDA Ratio | -47.99% | -151.28% | -507.24% | 0.00% | 0.00% |
| Operating Income | -265.86K | -1.36M | -4.63M | -2.02M | -2.04M |
| Operating Income Ratio | -47.99% | -168.38% | -519.17% | 0.00% | 0.00% |
| Total Other Income/Expenses | -154.12K | -52.56K | -4.45K | 0.00 | 0.00 |
| Income Before Tax | -419.98K | -1.41M | -4.64M | -2.02M | -2.04M |
| Income Before Tax Ratio | -75.81% | -174.90% | -519.67% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 52.56K | 4.45K | 2.00 | -2.04M |
| Net Income | -419.98K | -1.46M | -4.64M | -2.02M | -2.04M |
| Net Income Ratio | -75.81% | -181.43% | -520.17% | 0.00% | 0.00% |
| EPS | 0.00 | -0.01 | -0.02 | -0.01 | -0.01 |
| EPS Diluted | 0.00 | -0.01 | -0.02 | -0.01 | -0.01 |
| Weighted Avg Shares Out | 280.34M | 280.12M | 260.62M | 280.12M | 280.12M |
| Weighted Avg Shares Out (Dil) | 280.34M | 280.12M | 260.62M | 280.12M | 280.12M |
Source: https://incomestatements.info
Category: Stock Reports